对生物医学领域文章撤稿情况进行评估的研究综述。

IF 2.8 1区 哲学 Q1 MEDICAL ETHICS Accountability in Research-Policies and Quality Assurance Pub Date : 2024-08-01 Epub Date: 2023-01-15 DOI:10.1080/08989621.2022.2154660
Carla Brigitte Susan Kohl, Clovis Mariano Faggion
{"title":"对生物医学领域文章撤稿情况进行评估的研究综述。","authors":"Carla Brigitte Susan Kohl, Clovis Mariano Faggion","doi":"10.1080/08989621.2022.2154660","DOIUrl":null,"url":null,"abstract":"<p><p>This study aims to provide a comprehensive overview of previous research that has investigated retractions within the biomedical fields and assess their methodological quality. We searched three major electronic databases for articles on retractions within the biomedical field: PubMed, Web of Science, and Scopus. In total, 162 articles were included in the analysis. We evaluated their methodological quality using the items of \"a measurement tool to assess systematic reviews\" (AMSTAR-2) checklist and the Cochrane guidance. The studies had been published in more than 20 biomedical disciplines or fields of investigation, and two-thirds were published after 2017. Concerning methodology, none of the studies fulfilled all the suggested items; five studies did not meet any of the suggested AMSTAR-2 categories or Cochrane guidelines. The most prevalent reported reasons for retraction were fraud and plagiarism (21.0%). In summary, there has been increasing interest in assessing the characteristics and impact of retractions in the biomedical sciences. The studies cited types of misconduct more often than honest errors as a major reason for retraction. The methodological quality of the existing studies in this area appears to be suboptimal. Future investigators should improve upon this, particularly in the quality of the data selection and extraction.</p>","PeriodicalId":50927,"journal":{"name":"Accountability in Research-Policies and Quality Assurance","volume":" ","pages":"557-575"},"PeriodicalIF":2.8000,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A comprehensive overview of studies that assessed article retractions within the biomedical sciences.\",\"authors\":\"Carla Brigitte Susan Kohl, Clovis Mariano Faggion\",\"doi\":\"10.1080/08989621.2022.2154660\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study aims to provide a comprehensive overview of previous research that has investigated retractions within the biomedical fields and assess their methodological quality. We searched three major electronic databases for articles on retractions within the biomedical field: PubMed, Web of Science, and Scopus. In total, 162 articles were included in the analysis. We evaluated their methodological quality using the items of \\\"a measurement tool to assess systematic reviews\\\" (AMSTAR-2) checklist and the Cochrane guidance. The studies had been published in more than 20 biomedical disciplines or fields of investigation, and two-thirds were published after 2017. Concerning methodology, none of the studies fulfilled all the suggested items; five studies did not meet any of the suggested AMSTAR-2 categories or Cochrane guidelines. The most prevalent reported reasons for retraction were fraud and plagiarism (21.0%). In summary, there has been increasing interest in assessing the characteristics and impact of retractions in the biomedical sciences. The studies cited types of misconduct more often than honest errors as a major reason for retraction. The methodological quality of the existing studies in this area appears to be suboptimal. Future investigators should improve upon this, particularly in the quality of the data selection and extraction.</p>\",\"PeriodicalId\":50927,\"journal\":{\"name\":\"Accountability in Research-Policies and Quality Assurance\",\"volume\":\" \",\"pages\":\"557-575\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2024-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accountability in Research-Policies and Quality Assurance\",\"FirstCategoryId\":\"98\",\"ListUrlMain\":\"https://doi.org/10.1080/08989621.2022.2154660\",\"RegionNum\":1,\"RegionCategory\":\"哲学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL ETHICS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accountability in Research-Policies and Quality Assurance","FirstCategoryId":"98","ListUrlMain":"https://doi.org/10.1080/08989621.2022.2154660","RegionNum":1,"RegionCategory":"哲学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/15 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"MEDICAL ETHICS","Score":null,"Total":0}
引用次数: 0

摘要

本研究旨在全面概述以往对生物医学领域撤稿行为的调查研究,并评估其方法论质量。我们在三大电子数据库中搜索了有关生物医学领域撤稿的文章:PubMed、Web of Science 和 Scopus。共有 162 篇文章被纳入分析。我们使用 "评估系统性综述的测量工具"(AMSTAR-2)清单和 Cochrane 指南对这些文章的方法学质量进行了评估。这些研究发表于20多个生物医学学科或研究领域,其中三分之二发表于2017年之后。在方法学方面,没有一项研究符合所有建议的项目;有五项研究不符合AMSTAR-2建议的任何类别或Cochrane指南。据报告,撤稿最普遍的原因是欺诈和剽窃(21.0%)。总之,人们对评估生物医学领域撤稿的特点和影响越来越感兴趣。与诚实的错误相比,这些研究更多地将不当行为作为撤稿的主要原因。该领域现有研究的方法质量似乎不够理想。未来的研究人员应在这方面加以改进,特别是在数据选择和提取的质量方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
A comprehensive overview of studies that assessed article retractions within the biomedical sciences.

This study aims to provide a comprehensive overview of previous research that has investigated retractions within the biomedical fields and assess their methodological quality. We searched three major electronic databases for articles on retractions within the biomedical field: PubMed, Web of Science, and Scopus. In total, 162 articles were included in the analysis. We evaluated their methodological quality using the items of "a measurement tool to assess systematic reviews" (AMSTAR-2) checklist and the Cochrane guidance. The studies had been published in more than 20 biomedical disciplines or fields of investigation, and two-thirds were published after 2017. Concerning methodology, none of the studies fulfilled all the suggested items; five studies did not meet any of the suggested AMSTAR-2 categories or Cochrane guidelines. The most prevalent reported reasons for retraction were fraud and plagiarism (21.0%). In summary, there has been increasing interest in assessing the characteristics and impact of retractions in the biomedical sciences. The studies cited types of misconduct more often than honest errors as a major reason for retraction. The methodological quality of the existing studies in this area appears to be suboptimal. Future investigators should improve upon this, particularly in the quality of the data selection and extraction.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
14.70%
发文量
49
审稿时长
>12 weeks
期刊介绍: Accountability in Research: Policies and Quality Assurance is devoted to the examination and critical analysis of systems for maximizing integrity in the conduct of research. It provides an interdisciplinary, international forum for the development of ethics, procedures, standards policies, and concepts to encourage the ethical conduct of research and to enhance the validity of research results. The journal welcomes views on advancing the integrity of research in the fields of general and multidisciplinary sciences, medicine, law, economics, statistics, management studies, public policy, politics, sociology, history, psychology, philosophy, ethics, and information science. All submitted manuscripts are subject to initial appraisal by the Editor, and if found suitable for further consideration, to peer review by independent, anonymous expert referees.
期刊最新文献
Procrastination and inconsistency: Expressions of concern for publications with compromised integrity. A policy toolkit for authorship and dissemination policies may benefit NIH research consortia. A randomized trial alerting authors, with or without coauthors or editors, that research they cited in systematic reviews and guidelines has been retracted. Citation bias, diversity, and ethics. Industry effects on evidence: a case study of long-acting injectable antipsychotics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1